Clin2
NCT07447388Likely a fitNot yet recruiting

Medication reminder program for organ transplant patients

Transplant Patients

Part of Immune system & allergy clinical trials.

This study tests a program to help organ transplant patients remember to take their anti-rejection medicines correctly. It aims to improve medication adherence and overall health after transplantation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You can speak and understand Turkish.
  • You are able to read and write.
  • You have no mental health condition that affects communication.
  • You are ready to leave the hospital after your transplant (not in intensive care).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07364123Not yet recruiting
Staying on track with anti-rejection medicines after kidney transplant

This study tests ways to help kidney transplant patients take their anti-rejection medicines exactly as prescribed. It may help you keep your new kidney healthy and avoid complications.

Gaziantep, Şehitkamil
NCT07288918Not yet recruiting
Education program for organ transplant patients

This study tests an educational program for people who have had a liver or kidney transplant. It aims to improve quality of life, help patients stick to their anti-rejection medicines, and manage symptoms better.

Samsun, Samsun
NCT07592624Not yet recruiting
Video instructions for managing medications after kidney transplant

This trial tests whether a short instructional video helps patients manage their medications correctly after a kidney transplant and during follow-up visits. It may improve how well patients stick to their medication plan.

Rotterdam
NCT07769567Not yet recruiting
Better monitoring of anti-rejection medicines after transplant

This study looks at how to better manage anti-rejection medicines (tacrolimus and mycophenolate) in children and teens who have had an organ transplant. It uses text messages to help monitor drug levels, which might make treatment easier and safer.

NCT05459181Not yet recruiting
Personalizing anti-rejection medicines after a heart transplant

This study tests a new approach to managing anti-rejection medicines after a heart transplant. It uses special blood tests to see if your immune system is calm, so doctors can safely reduce the medicines and lower side effects.

NCT06652919Recruiting
Survey on medication leaflets for transplant patients

This study asks organ transplant patients and their caregivers to evaluate medication information leaflets. Your feedback could help make these leaflets clearer and easier to understand.

Münster, North Rhine-Westphalia

Hear when a new Transplant Patients trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.